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Introduction
Melanoma antigen L2 (MAGE-L2) belongs to the approximately 
60 gene MAGE family, which is divided into two subsets based on 
chromosomal location and expression pattern. MAGE proteins 
act as ubiquitin ligase regulators in conjunction with E3 RING 
ubiquitin ligases to form MAGE-RING ligases (MRLs). MAGEL2 has 
elevated expression in the hypothalamus and functions within 
a multi-subunit protein complex, which consists of MAGEL2, 
the TRIM27 E3 ubiquitin ligase, and the USP7 deubiquitinating 
enzyme. This complex is critical to the cellular process of recycling 
membrane proteins from endosomes through the retromer 
sorting pathway via ubiquitination and activation of the WASH 
actin nucleation promoting factor [1].
The physiological functions of MAGEL2 have been studied 
in several mouse models. Mice deficient in MAGEL2 expression 
in the suprachiasmatic nucleus show alterations in circadian 
rhythm and reduced motor activity, which may be mediated by 
the associated reduction in levels of orexin and orexin-positive 
neurons. These alterations in circadian rhythm appear linked to 
decreased fertility and early infertility in both male and female 
MAGEL-null mice [2]. MAGEL2-null mice also display neonatal 
growth retardation, significant weight gain status post weaning, 
and changes in metabolism in adulthood with increased adiposity 
[3]. Recently, a patient initially diagnosed with Opitz-C syndrome, 
a rare heterogeneous disease associated with psychomotor delay, 
trigonocephaly, and facial dysmorphisms, was identified to have 
a de novo nonsense mutation in MAGEL2 [4]. In addition, two 
families with lethal arthrogryposis multiplex congenita were found 
to have truncating mutations in MAGEL2 [5]. MAGEL2 has been 
most extensively studied in relation to the neurodevelopmental 
syndromes such as Prader-Willi Syndrome, and to a lesser extent, 
Schaaf-Yang Syndrome [6]. MAGEL2 is located on the proximal 
long arm of human chromosome 15 (15q11-q13), within the locus 
for Prader-Willi Syndrome. In Prader Willi Syndrome, MAGEL2R 
undergoes maternal imprinting and is typically paternally 
deleted or mutated. Its other two genetic subtypes are maternal 
uniparental disomy (20-30% of cases) and imprinting defect (1-
3%) [7].
Elucidating the phenotypic features of candidate genes, such 
as MAGEL2, will allow for improved targeted intervention. It 
is imperative that the associated clinical features of MAGEL2 
mutation be identified as early as possible that the severity of 
the associated syndrome are managed appropriately to improve 
health and long-term outcome for patients with this mutation.
Case Presentation
We present a 5-month-old female who was a product of a late 
preterm pregnancy and was born vaginally to non-consanguineous 
parents. The patient’s birth weight was 2700 grams. At 4.5 hours 
of life the patient was transferred to neonatal intensive care unit 
(NICU) due to apnea, abnormal eye movements, and hypotonia. 
The patient’s face appeared dysmorphic with microcephaly (head 
circumference of 32.5cm), micrognathia and esotropia. She also 
appeared to have disproportionately small hands and feet. The 
patient was lethargic with no interest in feedings and poor suck/
gag reflex. She was placed on feeds through a nasogastric tube. 
Her laboratory workup was significant for hypoglycemia and 
hypocalcemia. On the first day of life, an MRI showed Grade I 
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Abstract
We present a unique case of a patient with MAGEL2 mutation, her phenotypic 
features, and clinical course in comparison to Prader Willi Syndrome’s phenotype 
and course. Dysmorphic facial features with esotropia and micrognathia, feeding 
difficulties with poor suck, neonatal hypotonia, ineffective thermoregulation, 
sleep disturbance, small hands and feet are the features that were present in our 
patient at birth and prompted genetic evaluation. The melanoma antigen (MAGE) 
gene family of ubiquitin ligase regulators contains the MAGEL2 gene located 
within the Prader Willi locus. Although the MAGEL2 gene is located within the 
Prader-Willi Syndrome (PWS) locus, it is important to differentiate its associated 
phenotypic features not typically shared by PWS. At early childhood, those with 
PWS suffer hyperphagia, with the potential development of life-threatening 
obesity, diabetes, and right-sided heart failure into adulthood. Given the severity 
of these outcomes, we aim to describe the unique phenotypic features of MAGEL2 
mutation that guide clinical suspicion and early intervention for management of 
its complex presentation.
Keywords: MAGEL2; Prader-Willi Syndrome; Phenotypic features; Micrognathia; 
PWS
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intraventricular hemorrhage bilaterally and a hemorrhage within 
the pituitary gland. Her EEG showed bitemporal sharps and 
complexes concerning for subclinical seizures.
At Day 10 she was weaned to room air but continued having 
difficulty swallowing secretions with poor suck/gag reflexes and 
GERD. By week 4, the patient was less hypotonic but remained 
on tube feeds due to high aspiration risk without suck/gag reflex. 
The patient also had poor weight gain, intermittent pulmonary 
difficulties and was on and off oxygen and CPAP over the course 
of her hospital stay. Her ineffective thermoregulation was also 
monitored throughout. An Echocardiogram was done and revealed 
an atrial septal defect. At DOL 66, the G tube was placed with 
umbilical hernia repair. Physical therapist worked with the patient 
throughout hospital stay to assist with generalized hypotonia, 
head lag, and tightening of hands. Patient also had testing for 
level of Insulin-like-Growth-Factor-Binding-Protein 3, which was 
low at 520 ng/ml (Normal: 1039-3169 ng/ml). At DOL 75, the 
patient was discharged home with portable suction and G-tube. 
Patient was also referred to early intervention services. After 
discharge, the patient has been followed by pulmonary, endocrine, 
surgery, neurology, and gastroenterology. The patient’s weight 
at discharge was 3975 g. At 3 months, neurology reported that 
patient had diffuse hypotonia with poor neck control, continued 
tightening in the hands with limited mobility, and inability to fix 
or follow with eyes. Due to concerns for poor gastric emptying 
and possible aspiration, Interventional Radiology changed the G 
tube to a gastrojejunostomy (GJ) tube. With regards to pulmonary 
concerns, the patient underwent a sleep study, during which she 
had an episode of apnea lasting 15 seconds. The patient was 
admitted twice for pneumonia and continues to require daily 
nebulizer treatments, with nasal oxygen and CPAP as needed.
At 6 days of life, the baby underwent genetic testing for the 
MAGEL2c1912c pathogenic mutation, based on the history of 
the same mutation in her three-year-old brother and father. 
The results came back positive. The patient’s mother met with 
a genetic counselor prenatally at 13w2d and was educated that 
the recurrence risk for the condition was 50%. She declined all 
prenatal genetic testing, including amniocentesis, cell-free DNA 
testing, sequential screen, and detailed fetal anatomy scan. The 
patient’s father has the same mutation but is asymptomatic. 
The patient’s two-year-old brother tested negative for the 
MAGEL2c1912c pQ638 mutation. The patient’s three-year-
old brother tested positive for the same mutation and has a 
history of Pierre Robin sequence, hydronephrosis, microphallus, 
panhypopituitarism, GERD, dysphagia with G-tube and Nissen, 
asthma, OSA, micrognathia, developmental delay and autism.
Discussion
This patient’s phenotypic presentation is consistent with 
some of both major and minor criteria of Prader Willi syndrome 
(Table 1). Consistent with major criteria, our patient had 
neonatal hypotonia with poor suck, facial dysmorphism, and 
feeding problems. Consistent with minor criteria, our patient had 
infantile lethargy, small hands and feet, thick saliva, and sleep 
disturbance [8]. However, the patient also had several features 
outside of the major and minor criteria associated with Prader 
Willi syndrome, evidencing the unique features associated with 
the MAGEL2 mutation. Some of these features are also shared 
by her brother who has the same mutation. For instance, our 
patient had an MRI with suspicion for pituitary hemorrhage, 
and concern for developing hypopituitarism was expressed. The 
patient’s brother also has panhypopituitarism. The patient also 
had a low level of IGFBP-3, indicative of pituitary dysfunction 
as well. The patient also suffered ineffective thermoregulation, 
which further complicated her clinical course. The patient had 
EEG changes, which showed bitemporal sharps and complexes 
warranting a work up for subclinical seizures. Our patient also 
had tightening of the hands and feet, which was concerning for 
potential arthrogryposis. Her brother also has arthrogryposis, 
a feature which has been cited in one other case of MAGEL2 
mutation [6]. It was noted that she has abnormal eye movements, 
not characterized as esotropia, which will further complicate 
her development. The patient’s micrognathia, an unique feature 
associated with MAGEL2, has also been detrimental to her 
episodic apnea and feeding difficulties. Finally, with regards 
to cardiac findings, our patient has an atrial septal defect. This 
feature is not part of the major or minor criteria of PWS, but is 
consistent with the finding of cardiac anomalies as the most 
common congenital defect in PWS [9]. Our case underscores the 
importance of identification of features of Prader Willi Syndrome 
and other similar syndromes, in association with early genetic 
testing and early intervention.
Table 1: Phenotypic Features Present in Our Patient, Prader Willi Syndrome, and of MAGEL2 Gene Mutation.
Our Patient’s Features Prader Willi Major Criteria Prader Willi Minor Criteria Magel2
Facial Dysmorphism x
Developmental Delay x
Feeding Problems/Failure to x
Thrive in Infancy
Infantile Central Hypotonia x
Infantile Lethargy x
Abnormal Eye Movements X (Esotropia) x
(Not Well Characterized)
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Small Hands and Feet x
Sleep Disturbance/Sleep x
Apnea








Tightening of the Hands and x
Feet
(Possible Arthrogryposis)
Mutations in MAGEL2 portend lifelong management of 
associated complications, including global developmental delays, 
behavioral problems, and the dichotomous nature of nutritional/
growth complexities. In later infancy or early childhood patients 
with Prader-Willi syndrome, the period of hyperphagia ensues 
[10], with PWS as the most common known cause of childhood 
morbid obesity without treatment. In adulthood, patients with 
PWS can suffer behavioral problems, short stature, diabetes, sleep 
abnormalities including obstructive sleep apnea, and right-sided 
heart failure, with death typically within the fourth decade of 
life. Although our patient shares several features of Prader-Willi 
syndrome, her course through her childhood is incompletely 
defined, as evidenced by the disparities in presentation between 
her and her brother and the several discrepant features from 
Prader Willi diagnostic criteria. It is vital for parents to receive 
appropriate education regarding prenatal testing as well as 
anticipatory guidance at each phase of childhood [11]. It is 
pivotal for different pediatric specialists to work together to 
manage syndromes less commonly described in order to improve 
patients’ long-term outcome. Moving forward, it will be critical to 
continue monitoring our patient’s development, to see which of 
these features she will share and what features will be unique to 
MAGEL2 mutation, and how to manage her unique presentation 
appropriately.
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